Are you Dr. Oton?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 98 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
700 Delaware St
Davis Pavilion, Mc 4001
Denver, CO 80204Phone+1 303-436-6171Fax+1 303-436-3801
Summary
- Dr. Ana Oton, MD is an oncologist in Denver, Colorado. She is currently licensed to practice medicine in Colorado and Pennsylvania. She is affiliated with Denver Health and is an Assistant Professor at University of Colorado School of Medicine.
Education & Training
- UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2004 - 2007
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2001 - 2004
- Central University of VenezuelaClass of 1998
Certifications & Licensure
- CO State Medical License 2007 - 2025
- PA State Medical License 2004 - 2007
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma Start of enrollment: 2007 Jul 01
- S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2008 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsCancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015Christian Rolfo, Christian Caglevic, Denisse Bretel, David S. Hong, Luis E. Raez
ESMO Open. 2016-06-01 - 13 citationsDrug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United StatesLisa M. Hess, Zhanglin Lin Cui, Xiaohong Ivy Li, Ana B Oton, Scott Shortenhaus
Journal of Medical Economics. 2018-05-11 - 23 citationsTreatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy.Suzanne McMullen, Lisa M. Hess, Edward S. Kim, Benjamin Levy, Mohamed K. Mohamed
The Patient. 2019-04-01
Press Mentions
- Phase II Trial of Efatutazone Shows Challenge of Matching Treatment to PopulationApril 8th, 2014
Professional Memberships
- Member